• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 CBPR 方法提高 HPV 疫苗接种率对减少年轻同胞间免疫接种差异的辅助作用。

Ancillary Benefit of Increased HPV Immunization Rates Following a CBPR Approach to Address Immunization Disparities in Younger Siblings.

机构信息

Department of Pediatrics, Johns Hopkins University School of Medicine, 1800 Orleans Street, Baltimore, MD, 21287, USA.

Department of Pediatrics, Medical College of Wisconsin, 8701 West Watertown Plank Road, Milwaukee, WI, 53226, USA.

出版信息

J Community Health. 2019 Jun;44(3):544-551. doi: 10.1007/s10900-018-00610-9.

DOI:10.1007/s10900-018-00610-9
PMID:30604221
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6504598/
Abstract

Increasing HPV vaccination rates may decrease the disproportionately high HPV-associated disease incidence and mortality in African Americans (AA) and lower socioeconomic individuals. Data from a community-based participatory research (CBPR) study addressing immunization disparities among 19-35 month old children was analyzed to identify ancillary benefits in HPV immunization rates for adolescent siblings. Sub-study analysis inclusion criteria: AA (N = 118), 13-17 years old, younger sibling enrolled in parent study, and enrolled ≥ 9 months. Parent/caregiver interventions included: a web-based immunization toolkit with information on age-appropriate vaccines; a multimedia community outreach campaign; and reminder mailings. HPV up-to-date (UTD) status was defined as Wisconsin Immunization Registry (WIR) documentation of at least three HPV vaccines. McNemar's test compared pre/post intervention HPV status. Two dependent proportions testing compared the proportion of adolescents that became UTD in the study cohort, City of Milwaukee, and State of Wisconsin. Parents/caregivers perceived that 92% of adolescents were HPV-UTD, while only 24% had a WIR-verified HPV-UTD status. Baseline UTD status of the younger siblings 19-35 month old 4:3:1:3:3:1:4 antigen series was 63%, which increased to 86% at study completion. Adolescent's HPV-UTD immunization status increased from 30 (25%) at enrollment to 54 (46%) at study completion [p = 0.004]. A statistically significant larger proportion of adolescents became HPV-UTD in the study cohort (20%) compared to the City of Milwaukee [14%, p = 0.042] and the State of Wisconsin [14%, p = 0.046]. A culturally-tailored CBPR approach targeting parents/caregivers of younger AA children can have significant ancillary benefit to increase HPV immunization rates in adolescent siblings.

摘要

提高 HPV 疫苗接种率可能会降低非裔美国人(AA)和社会经济地位较低人群中 HPV 相关疾病发病率和死亡率的不成比例现象。对一项基于社区的参与性研究(CBPR)进行了数据分析,该研究旨在解决 19-35 个月大的儿童中的免疫接种差距问题,以确定青少年兄弟姐妹 HPV 免疫接种率的辅助益处。子研究分析纳入标准:AA(N=118),13-17 岁,年龄较小的兄弟姐妹参加了父母研究,并且参加时间≥9 个月。父母/照顾者干预措施包括:一个包含适龄疫苗信息的基于网络的免疫工具包;多媒体社区外展活动;以及提醒邮件。HPV 最新状态(UTD)定义为威斯康星州免疫登记处(WIR)记录的至少三种 HPV 疫苗。McNemar 检验比较了干预前后 HPV 状态。两个独立比例检验比较了研究队列、密尔沃基市和威斯康星州青少年成为 UTD 的比例。父母/照顾者认为 92%的青少年 HPV 是 UTD 的,而只有 24%的人在 WIR 中核实了 HPV-UTD 状态。年龄较小的兄弟姐妹 19-35 个月 4:3:1:3:3:1:4 抗原系列的基线 UTD 状态为 63%,在研究完成时增加到 86%。青少年 HPV-UTD 免疫接种状况从入学时的 30(25%)增加到研究结束时的 54(46%)[p=0.004]。与密尔沃基市[14%,p=0.042]和威斯康星州[14%,p=0.046]相比,研究队列中青少年成为 HPV-UTD 的比例显著增加(20%)。针对年轻 AA 儿童的父母/照顾者的文化上量身定制的 CBPR 方法可以显著提高青少年兄弟姐妹的 HPV 免疫接种率。

相似文献

1
Ancillary Benefit of Increased HPV Immunization Rates Following a CBPR Approach to Address Immunization Disparities in Younger Siblings.基于 CBPR 方法提高 HPV 疫苗接种率对减少年轻同胞间免疫接种差异的辅助作用。
J Community Health. 2019 Jun;44(3):544-551. doi: 10.1007/s10900-018-00610-9.
2
Improving Immunization Rates Through Community-Based Participatory Research: Community Health Improvement for Milwaukee's Children Program.通过基于社区的参与性研究提高免疫接种率:密尔沃基儿童社区健康改善项目
Prog Community Health Partnersh. 2016 Spring;10(1):19-30. doi: 10.1353/cpr.2016.0009.
3
Effect of age at initiation of the human papillomavirus vaccine on the association between race/ethnicity and completion of the vaccine series.人乳头瘤病毒疫苗开始接种时的年龄对种族/族裔与疫苗系列接种完成情况之间关联的影响。
Vaccine. 2024 Apr 19;42(11):2827-2836. doi: 10.1016/j.vaccine.2024.03.050. Epub 2024 Mar 21.
4
Immunization coverage levels among 19- to 35-month-old children in 4 diverse, medically underserved areas of the United States.美国4个不同的医疗服务欠缺地区19至35个月大儿童的免疫接种覆盖率水平。
Pediatrics. 2004 Apr;113(4):e296-302. doi: 10.1542/peds.113.4.e296.
5
School-based human papillomavirus vaccination program for increasing vaccine uptake in an underserved area in Texas.德克萨斯州一个服务不足地区基于学校的人乳头瘤病毒疫苗接种计划,以提高疫苗接种率。
Papillomavirus Res. 2019 Dec;8:100189. doi: 10.1016/j.pvr.2019.100189. Epub 2019 Oct 22.
6
Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series.与三剂人乳头瘤病毒疫苗系列接种完成时间延迟相关的照顾者和青少年因素。
Vaccine. 2018 Mar 7;36(11):1491-1499. doi: 10.1016/j.vaccine.2017.12.060. Epub 2018 Feb 7.
7
The association of initiating HPV vaccination at ages 9-10 years and up-to-date status among adolescents ages 13-17 years, 2016-2020.9-10 岁开始接种 HPV 疫苗与 13-17 岁青少年 HPV 疫苗接种及时率的相关性。2016-2020 年。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2175555. doi: 10.1080/21645515.2023.2175555. Epub 2023 Feb 7.
8
Effect of a Health Care Professional Communication Training Intervention on Adolescent Human Papillomavirus Vaccination: A Cluster Randomized Clinical Trial.卫生保健专业人员沟通培训干预对青少年人乳头瘤病毒疫苗接种的影响:一项群组随机临床试验。
JAMA Pediatr. 2018 May 7;172(5):e180016. doi: 10.1001/jamapediatrics.2018.0016.
9
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2020.全国、地区、州和选定的局部地区 13-17 岁青少年疫苗接种覆盖率 - 美国,2020 年。
MMWR Morb Mortal Wkly Rep. 2021 Sep 3;70(35):1183-1190. doi: 10.15585/mmwr.mm7035a1.
10
Area-based socioeconomic factors and Human Papillomavirus (HPV) vaccination among teen boys in the United States.美国青少年男性基于地区的社会经济因素与人乳头瘤病毒(HPV)疫苗接种情况
BMC Public Health. 2017 Jul 14;18(1):19. doi: 10.1186/s12889-017-4567-2.

引用本文的文献

1
Health Equity and Human Papillomavirus Vaccine Interventions for Adolescents: A Systematic Review.青少年的健康公平与人类乳头瘤病毒疫苗干预措施:一项系统综述
Vaccines (Basel). 2025 Apr 30;13(5):485. doi: 10.3390/vaccines13050485.
2
Community-based participatory research (CBPR) approaches in vaccination promotion: a scoping review.基于社区的参与式研究(CBPR)在疫苗推广中的应用:范围综述。
Int J Equity Health. 2024 Nov 5;23(1):227. doi: 10.1186/s12939-024-02278-1.
3
Applying a Participatory Action Research Approach to Engage an Australian Culturally and Linguistically Diverse Community around Human Papillomavirus Vaccination: Lessons Learned.

本文引用的文献

1
Association of both consistency and strength of self-reported clinician recommendation for HPV vaccination and HPV vaccine uptake among 11- to 12-year-old children.11至12岁儿童中自我报告的临床医生对HPV疫苗接种的推荐的一致性和力度与HPV疫苗接种率之间的关联。
Vaccine. 2017 Oct 27;35(45):6122-6128. doi: 10.1016/j.vaccine.2017.09.056. Epub 2017 Sep 27.
2
Reasons for acceptance or refusal of Human Papillomavirus Vaccine in a California pediatric practice.加利福尼亚州一家儿科诊所中接受或拒绝人乳头瘤病毒疫苗的原因
Papillomavirus Res. 2017 Jun;3:42-45. doi: 10.1016/j.pvr.2017.01.002. Epub 2017 Jan 17.
3
Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices.
应用参与式行动研究方法,让澳大利亚文化和语言背景多样的社区参与人乳头瘤病毒疫苗接种:经验教训。
Vaccines (Basel). 2024 Aug 28;12(9):978. doi: 10.3390/vaccines12090978.
4
Community Engagement in Vaccination Promotion: Systematic Review and Meta-Analysis.社区参与疫苗推广:系统评价和荟萃分析。
JMIR Public Health Surveill. 2024 May 10;10:e49695. doi: 10.2196/49695.
5
A systematic review of interventions to promote HPV vaccination globally.全球促进 HPV 疫苗接种的干预措施的系统评价。
BMC Public Health. 2023 Jun 29;23(1):1262. doi: 10.1186/s12889-023-15876-5.
6
Moving vaccination beyond partisan politics.将疫苗接种超越党派政治。
Vaccine. 2022 Jun 21;40(28):3815-3817. doi: 10.1016/j.vaccine.2022.05.049. Epub 2022 May 27.
二剂程序接种人乳头瘤病毒疫苗的应用 - 更新的免疫实践咨询委员会建议。
MMWR Morb Mortal Wkly Rep. 2016 Dec 16;65(49):1405-1408. doi: 10.15585/mmwr.mm6549a5.
4
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2015.国家、地区、州和选定的局部地区 13-17 岁青少年疫苗接种覆盖率 - 美国,2015 年。
MMWR Morb Mortal Wkly Rep. 2016 Aug 26;65(33):850-8. doi: 10.15585/mmwr.mm6533a4.
5
Missing the Target for Routine Human Papillomavirus Vaccination: Consistent and Strong Physician Recommendations Are Lacking for 11- to 12-Year-Old Males.错失常规人乳头瘤病毒疫苗接种目标:11至12岁男性缺乏持续且有力的医生建议。
Cancer Epidemiol Biomarkers Prev. 2016 Oct;25(10):1435-1446. doi: 10.1158/1055-9965.EPI-15-1294. Epub 2016 Aug 2.
6
Human Papillomavirus-Associated Cancers - United States, 2008-2012.人乳头瘤病毒相关癌症 - 美国,2008-2012 年。
MMWR Morb Mortal Wkly Rep. 2016 Jul 8;65(26):661-6. doi: 10.15585/mmwr.mm6526a1.
7
Improving Immunization Rates Through Community-Based Participatory Research: Community Health Improvement for Milwaukee's Children Program.通过基于社区的参与性研究提高免疫接种率:密尔沃基儿童社区健康改善项目
Prog Community Health Partnersh. 2016 Spring;10(1):19-30. doi: 10.1353/cpr.2016.0009.
8
Practice- and Community-Based Interventions to Increase Human Papillomavirus Vaccine Coverage: A Systematic Review.基于实践和社区的干预措施以提高人乳头瘤病毒疫苗覆盖率:系统评价。
JAMA Pediatr. 2015 Jul;169(7):686-92. doi: 10.1001/jamapediatrics.2015.0310.
9
Evaluation of a social marketing campaign to increase awareness of immunizations for urban low-income children.一项旨在提高城市低收入儿童免疫接种意识的社会营销活动评估。
WMJ. 2015 Feb;114(1):10-5.
10
Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.九价人乳头瘤病毒(HPV)疫苗的使用:免疫实践咨询委员会的HPV疫苗接种最新建议
MMWR Morb Mortal Wkly Rep. 2015 Mar 27;64(11):300-4.